Status: current, Sufficiently defined by necessary conditions definition status. Date: 30-Apr 2022. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5034032018 | Product containing only cefuroxime and clavulanic acid in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 5034033011 | Cefuroxime and clavulanic acid only product in oral dose form | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing only cefuroxime and clavulanic acid in oral dose form (medicinal product form) | Is a | Product containing only cefuroxime and clavulanic acid (medicinal product) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing only cefuroxime and clavulanic acid in oral dose form (medicinal product form) | Is a | Product containing cefuroxime and clavulanic acid in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing only cefuroxime and clavulanic acid in oral dose form (medicinal product form) | Has manufactured dose form | Oral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing only cefuroxime and clavulanic acid in oral dose form (medicinal product form) | Plays role | Antibacterial therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Product containing only cefuroxime and clavulanic acid in oral dose form (medicinal product form) | Has active ingredient | Cefuroxime | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing only cefuroxime and clavulanic acid in oral dose form (medicinal product form) | Has active ingredient | Clavulanic acid | true | Inferred relationship | Existential restriction modifier | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely cefuroxime (as cefuroxime axetil) 500 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) | Is a | True | Product containing only cefuroxime and clavulanic acid in oral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR